Hutchinson Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$456K Buy
18,926
+3
+0% +$78 0.08% 72
2026
Q1
$531K Sell
18,923
-1,851
-9% -$49.3K 0.1% 61
2025
Q4
$517K Sell
20,774
-3,146
-13% -$79.3K 0.09% 64
2025
Q3
$609K Sell
23,920
-215
-0.9% -$5.31K 0.11% 62
2025
Q2
$585K Buy
24,135
+39
+0.2% +$910 0.11% 60
2025
Q1
$611K Sell
24,096
-3,150
-12% -$82.4K 0.12% 57
2024
Q4
$723K Sell
27,246
-4,766
-15% -$129K 0.14% 56
2024
Q3
$926K Sell
32,012
-2,092
-6% -$61K 0.18% 53
2024
Q2
$954K Sell
34,104
-799
-2% -$22K 0.2% 50
2024
Q1
$969K Sell
34,903
-917
-3% -$25.4K 0.2% 45
2023
Q4
$1.03M Sell
35,820
-1,306
-4% -$39.5K 0.22% 46
2023
Q3
$1.23M Sell
37,126
-434
-1% -$15.3K 0.29% 40
2023
Q2
$1.38M Sell
37,560
-2,117
-5% -$82.4K 0.32% 38
2023
Q1
$1.62M Sell
39,677
-125
-0.3% -$5.4K 0.42% 31
2022
Q4
$2.04M Sell
39,802
-1,626
-4% -$78K 0.53% 29
2022
Q3
$1.81M Buy
41,428
+60
+0.1% +$2.92K 0.49% 30
2022
Q2
$2.17M Buy
41,368
+767
+2% +$39.1K 0.56% 27
2022
Q1
$2.1M Sell
40,601
-3,827
-9% -$199K 0.49% 27
2021
Q4
$2.62M Sell
44,428
-3,512
-7% -$174K 0.58% 27
2021
Q3
$2.06M Sell
47,940
-352
-0.7% -$15.6K 0.5% 29
2021
Q2
$1.89M Sell
48,292
-334
-0.7% -$13K 0.47% 28
2021
Q1
$1.76M Buy
48,626
+1,600
+3% +$56.8K 0.44% 29
2020
Q4
$1.73M Sell
47,026
-1,654
-3% -$60.7K 0.45% 31
2020
Q3
$1.7M Sell
48,680
-56
-0.1% -$1.96K 0.5% 32
2020
Q2
$1.51M Sell
48,736
-4,532
-9% -$154K 0.47% 32
2020
Q1
$1.65M Sell
53,268
-2,579
-5% -$87.9K 0.55% 34
2019
Q4
$2.08M Buy
55,847
+4,242
+8% +$151K 0.54% 36
2019
Q3
$1.76M Buy
51,605
+208
+0.4% +$7.56K 0.48% 38
2019
Q2
$2.11M Sell
51,397
-1,521
-3% -$60.4K 0.59% 35
2019
Q1
$2.13M Sell
52,918
-336
-0.6% -$13.5K 0.64% 32
2018
Q4
$2.21M Sell
53,254
-448
-0.8% -$18.6K 0.74% 31
2018
Q3
$2.25M Sell
53,702
-753
-1% -$29K 0.62% 32
2018
Q2
$1.87M Sell
54,455
-461
-0.8% -$15.8K 0.58% 29
2018
Q1
$1.85M Hold
54,916
0.54% 27
2017
Q4
$1.89M Sell
54,916
-531
-1% -$18.1K 0.49% 26
2017
Q3
$1.88M Sell
55,447
-1,091
-2% -$35.1K 0.51% 25
2017
Q2
$1.8M Sell
56,538
-316
-0.6% -$9.96K 0.51% 25
2017
Q1
$1.84M Sell
56,854
-1,102
-2% -$34.7K 0.51% 26
2016
Q4
$1.79M Sell
57,956
-533
-0.9% -$16.3K 0.49% 27
2016
Q3
$1.88M Sell
58,489
-1,712
-3% -$57.2K 0.59% 24
2016
Q2
$2.01M Sell
60,201
-704
-1% -$22.5K 0.61% 26
2016
Q1
$1.71M Sell
60,905
-873
-1% -$24.9K 0.54% 24
2015
Q4
$1.89M Buy
61,778
+313
+0.5% +$9.85K 0.59% 24
2015
Q3
$1.83M Sell
61,465
-2,792
-4% -$89.5K 0.61% 25
2015
Q2
$2.04M Sell
64,257
-3,891
-6% -$127K 0.63% 25
2015
Q1
$2.25M Buy
68,148
+316
+0.5% +$10K 0.7% 26
2014
Q4
$2M Sell
67,832
-3,761
-5% -$108K 0.57% 30
2014
Q3
$2.01M Sell
71,593
-1,869
-3% -$52.5K 0.59% 29
2014
Q2
$2.07M Sell
73,462
-1,860
-2% -$53K 0.57% 28
2014
Q1
$2.29M Sell
75,322
-1,028
-1% -$30.7K 0.68% 26
2013
Q4
$2.22M Buy
76,350
+1,556
+2% +$45.3K 0.63% 28
2013
Q3
$2.04M Sell
74,794
-1,760
-2% -$47.9K 0.66% 27
2013
Q2
$2.03M Buy
+76,554
New +$2.12M 0.68% 27

Other funds holding PFE

Hutchinson Capital Management's PFE Position: Q2 2026 in Review

Hutchinson Capital Management increased its Pfizer (PFE) stake by 0.02% in Q2 2026, buying an estimated $78 and bringing the position to 18,926 shares worth $456K. The position accounts for 0.08% of the portfolio, ranked #72.

Hutchinson Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.62M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hutchinson Capital Management held 18,926 shares of Pfizer worth $456K as of Q2 2026.
  • Hutchinson Capital Management bought 3 Pfizer shares in Q2 2026, an estimated $78.
  • Pfizer made up 0.08% of Hutchinson Capital Management's portfolio in Q2 2026, its #72 holding.
  • Hutchinson Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Hutchinson Capital Management's Pfizer position peaked at $2.62M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hutchinson Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.